The expression of this gene is under the fine-tuned regulation of signaling pathways such as IL-4/STAT6, and targeted interventions against its downstream signaling have been successfully applied in treating severe asthma and chronic spontaneous urticaria, affirming the pivotal value of FCER1A as a critical immune marker and therapeutic target [26,39]. Here, IL4 is linked to asthma.